1型糖尿病合并自身免疫病患者的特征:DPV登记研究
合并AID者女性更多、糖尿病病程更长,合并Addison病(AD)或桥本甲状腺炎(HT)者每日胰岛素剂量更高,HT或Graves病(GD)者神经病变更常见而微量白蛋白尿更少。
要点
- 合并AID的T1DM患者女性比例更高、糖尿病病程更长。
- 合并AD或HT的T1DM患者每日胰岛素剂量高于孤立T1DM。
- 合并HT或GD者神经病变更常见、微量白蛋白尿更少。
核心结论
- 合并自身免疫病的T1DM患者与孤立T1DM相比呈现异质性差异。
- T1DM合并AD或HT需要更多胰岛素。
- 合并HT或GD者神经病变率更高而微量白蛋白尿率更低。
研究设计与样本
- 基于DPV前瞻性糖尿病随访登记,检索T1DM合并HT、GD和/或AD的病例。
- 采用多因素回归模型,基础调整年龄、性别、糖尿病病程、移民背景和胰岛素方案类型;微血管终点额外调整糖化血红蛋白。
主要发现
- 合并AID者女性比例更高(54.7% vs 32.0%,P < .001)。
- 合并AID者糖尿病病程更长(7.9 [4.2-12.5] vs 6.7 [2.7-12.9]年,P < .001)。
- 调整后每日胰岛素剂量在AD和HT中高于孤立T1DM(0.858 ± 0.032和0.813 ± 0.005 vs 0.793 ± 0.001 IU/kg/天)。
- 视网膜病变在HT中较少(1.5%),在GD中较多(3.1%),孤立T1DM为1.8%。
- 微量白蛋白尿在GD和HT中较少(10.6%和14.3% vs 15.5%),神经病变更常见(2.1%和1.8% vs 0.8%),所有P < .05。
临床怎么用
- 对T1DM合并AD或HT的患者,需注意胰岛素需求量可能更高。
- 对T1DM合并HT或GD的患者,应关注神经病变筛查。
- 对T1DM合并HT或GD的患者,微量白蛋白尿发生率较低但仍需常规监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Autoimmune diseases affect ~8% of the population. Type 1 diabetes mellitus (T1DM) is linked to other autoimmune diseases (AIDs), such as autoimmune thyroid disease or Addison's disease (AD), that may impact diabetes therapy and outcome. OBJECTIVE: To analyze demographic and clinical characteristics of other AIDs in T1DM from a large standardized registry, the Prospective Diabetes Follow-up Registry (DPV). METHODS: We searched the registry for T1DM with the additional diagnosis of Hashimoto's thyroiditis (HT), Graves' disease (GD), and/or AD. T1DM with other AIDs (n = 6166, 5.4%) were compared with isolated T1DM (n = 107 457). For group comparisons, we used multivariable regression models with age, sex, diabetes duration, migration background, and type of insulin regimen as basic adjustments (microvascular endpoints: additionally adjusted for glycated hemoglobin). RESULTS: Patients with additional AIDs were more often female (54.7 vs 32.0%, P < .001) and had a longer diabetes duration (7.9 [4.2-12.5] vs 6.7 [2.7-12.9] years, P < .001). After adjustment, daily insulin dosage was higher in AD and HT than in isolated T1DM (0.858 ± 0.032 and 0.813 ± 0.005 vs 0.793 ± 0.001 IU/kg per day). Retinopathy was less common in HT (1.5%), whereas it was more frequent in GD (3.1%) than in isolated T1DM (1.8%). In both GD and HT, microalbuminuria occurred less often (10.6% and 14.3% vs 15.5%) and neuropathy (2.1% and 1.8% vs 0.8%) was more common than in isolated T1DM. All P < .05. CONCLUSION: T1DM with additional AIDs show heterogeneous differences compared with isolated T1DM. T1DM plus AD or HT requires more insulin. Further, the rate of neuropathy is higher in HT or GD, whereas the rate of microalbuminuria is lower.
引用
- Prinz N, Tittel SR, Bachran R, et al. Characteristics of Patients with Type 1 Diabetes and Additional Autoimmune Disease in the DPV Registry. J Clin Endocrinol Metab. 2021. PMID: 34061946. doi:10.1210/clinem/dgab376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。